BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Press Releases

  Mainz Biomed and Liquid Biosciences Make Groundbreaking Discovery of mRNA Biomarkers for Blood Based Detection of Pancreatic Cancer

  March 13, 2025

   · 

  5 min read
• Press Releases

  scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025

  March 13, 2025

   · 

  1 min read
• Press Releases

  Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

  March 13, 2025

   · 

  1 min read
• Press Releases

  Kewaunee Scientific Reports Results for Third Quarter of Fiscal Year 2025

  March 13, 2025

   · 

  18 min read
• Press Releases

  STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab), now available in the United States

  March 13, 2025

   · 

  10 min read
• Press Releases

  Zai Lab Announces Acceptance of Biologics License Application for TIVDAK for the Treatment of Patients with Recurrent or Metastatic Cervical Cancer

  March 13, 2025

   · 

  6 min read
• Press Releases

  BioCity Biopharmaceutics Co., Ltd. Announces Clinical Collaboration to Evaluate BC3195 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Locally Advanced or Metastatic Solid Tumors

  March 13, 2025

   · 

  3 min read
• Press Releases

  Pharming Group reports fourth quarter and full year 2024 financial results and provides business update

  March 13, 2025

   · 

  40 min read
• Press Releases

  Metagenomi Announces Publication in Nature Communications on Large Gene Integration Advances Using Novel, Compact CRISPR-associated transposase (CAST) Systems

  March 13, 2025

   · 

  5 min read
• Press Releases

  Faeth Therapeutics and The GOG Foundation, Inc. (GOG-F) Launch First Phase 2 Combination Trial for Sapanisertib-Serabelisib in Patients With Endometrial Cancer

  March 13, 2025

   · 

  6 min read